ArticleBMJ (Clinical research ed.)2004
Lessons from the withdrawal of rofecoxib: France has policy for overall assessment of public health impact of new drugs.
Lucien AbenhaimPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleBMJ (Clinical research ed.)2004
Lucien AbenhaimPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.